07:00 , Jun 25, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Myosin heavy chain 9 (MYH9); leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5; GPR49)

Gastrointestinal disease INDICATION: Colitis Mouse studies suggest inhibiting MYH9 could help treat colitis. In a mouse model of chemical-induced colitis, levels of MYH9 were higher at sites of colonic epithelial injury and on LGR5-positive stem...
08:00 , Nov 11, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Herpes simplex virus (HSV) Myosin heavy chain 9 (MYH9); myosin light chain kinase (MYLK; MLCK) Cell culture and mouse studies suggest that inhibiting MYH9...